DMAA SEC Filings: 8-K, 10-Q, S-3 & 424B

Financials

TYPE

HEADLINE

FILED AT

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Aug 14, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

May 14, 2026

10-K

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Apr 15, 2026

NT 10-K

Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405

Apr 1, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Nov 18, 2025

NT 10-Q

Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB

Nov 14, 2025

News

TYPE

HEADLINE

FILED AT

Prospectus

TYPE

HEADLINE

FILED AT

425

Form 425 - Prospectuses and communications, business combinations

Oct 21, 2026

425

Form 425 - Prospectuses and communications, business combinations

Sep 14, 2026

425

Form 425 - Prospectuses and communications, business combinations

Jul 20, 2026

425

Form 425 - Prospectuses and communications, business combinations

May 5, 2026

424B4

SHARE RESALE REGISTRATION | Shares amount: 20,000,000 | Share price: $10 | Offering amount: $200,000,000

Jan 29, 2025

Registrations

TYPE

HEADLINE

FILED AT

POS AM

Form POS AM - Post-Effective amendments for registration statement

Jan 22, 2025

POS AM

Form POS AM - Post-Effective amendments for registration statement

Jan 14, 2025

8-A12B

Form 8-A12B - Registration of securities [Section 12(b)]

Jan 7, 2025

S-1/A

SHARE RESALE REGISTRATION

Jan 6, 2025

S-1/A

SHARE RESALE REGISTRATION | Shares amount: 20,000,000 | Share price: $10 | Offering amount: $200,000,000

Dec 9, 2024

S-1/A

INITIAL REGISTRATION FOR OFFERING | Shares amount: 20,000,000 | Share price: $10.00 | Offering amount: $200,000,000.00 EFFECTIVE, DATED 2025-01-07

Nov 25, 2024

Proxies

TYPE

HEADLINE

FILED AT

DEFR14A

Form DEFR14A - Revised definitive proxy soliciting materials

Apr 16, 2026

DEF 14A

Form DEF 14A - Other definitive proxy statements

Apr 14, 2026

PRE 14A

Form PRE 14A - Other preliminary proxy statements

Mar 27, 2026

Ownerships

TYPE

HEADLINE

FILED AT

SCHEDULE 13G/A

Karpus Management, Inc. (Filed by)

Aug 14, 2026

SCHEDULE 13G/A

First Trust Capital Management L.P. (Filed by)

Aug 14, 2026

SCHEDULE 13G/A

GLAZER CAPITAL, LLC (Filed by)

Aug 13, 2026

SCHEDULE 13G/A

MIZUHO FINANCIAL GROUP INC (Filed by)

Aug 13, 2026

SCHEDULE 13G

Feis Equities LLC (Filed by)

Jun 26, 2026

SCHEDULE 13G

MIZUHO FINANCIAL GROUP INC (Filed by)

May 14, 2026

Other

TYPE

HEADLINE

FILED AT

EFFECT

Form EFFECT - Notice of Effectiveness

Jan 28, 2025

CORRESP

Form CORRESP - Correspondence

Jan 23, 2025

CORRESP

Form CORRESP - Correspondence

Jan 23, 2025

EFFECT

Form EFFECT - Notice of Effectiveness

Jan 8, 2025

CORRESP

Form CORRESP - Correspondence

Jan 3, 2025

CORRESP

Form CORRESP - Correspondence

Jan 3, 2025

Drugs Made In America Acquisition Corp. Ordinary Shares DMAA · SEC Filings